Z-0334-2016 Class II Terminated
FDA device recall Z-0334-2016 was initiated by Becton, Dickinson And Company, BD Biosciences on Oct 30, 2015 and is designated Class II. Reason for recall: Three lots of CD64 (MD22) are contaminated with CD4 antibody. The recall status is terminated (terminated May 27, 2016). Affected quantity: 23 vials.
Recall details
- Product Type
- Devices
- Report Date
- Dec 2, 2015
- Initiation Date
- Oct 30, 2015
- Termination Date
- May 27, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23 vials
Product description
BD CD64 APC-R700; Analyte Specific Reagent; Model 657701; Lot No. 4344945, 5037611 and 5063945. Hematology - used as analyte specific reagent - contamination leads to possibility of unexpected staining pattern.
Reason for recall
Three lots of CD64 (MD22) are contaminated with CD4 antibody.
Distribution pattern
Distributed in the states of FL, WA, PA, IL, GA, RI, TX, ND, and IA.
Code information
Model 657701; Lot No. 4344945, 5037611, both with expiry date of 31 DEC 2015; and 5063945 with expiry dte of 29 FEB 2016.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0334-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026